טוען...
The efficacy and safety of 10 mg/day vortioxetine compared to placebo for adult major depressive disorder: a meta-analysis
BACKGROUND: There is a growing interest in vortioxetine in major depressive disorder (MDD). OBJECTIVES: This meta-analysis aimed to assess the efficacy and safety of 10 mg/day (mg/d) vortioxetine compared to placebo for MDD in adult. METHODS: Eight randomly controlled trials (RCTs) about the treatme...
שמור ב:
| הוצא לאור ב: | Afr Health Sci |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Makerere Medical School
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6531944/ https://ncbi.nlm.nih.gov/pubmed/31149002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4314/ahs.v19i1.48 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|